| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |